JMJD3 can be considered a tumor suppressor based on the finding that it increases the expression levels of the tumor suppressors p16INK4a, p14ARF, and p15INK4B and the activities of the tumor suppressors p53 and Rb. Here, KDM6B is linked to neoplasm.